Pharmala Biotech Holdings (XCNQ:MDMA) Pre-Tax Income : C$-0.70 Mil (TTM As of Nov. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Pharmala Biotech Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Pharmala Biotech Holdings's pretax income for the three months ended in Nov. 2024 was C$-0.48 Mil. Its pretax income for the trailing twelve months (TTM) ended in Nov. 2024 was C$-0.70 Mil. Pharmala Biotech Holdings's pretax margin was -840.35%.

During the past 4 years, Pharmala Biotech Holdings's highest Pretax Margin was -79.61%. The lowest was -1264.10%. And the median was -146.62%.

Pharmala Biotech Holdings Pre-Tax Income Historical Data

The historical data trend for Pharmala Biotech Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings Pre-Tax Income Chart

Pharmala Biotech Holdings Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Pre-Tax Income

-2.51

-0.99

-0.78

-0.82

Pharmala Biotech Holdings Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	Aug24	Nov24
Pre-Tax Income	Get a 7-Day Free Trial									-0.08	0.04	-0.22	-	-0.48

Competitive Comparison of Pharmala Biotech Holdings's Pre-Tax Income

For the Biotechnology subindustry, Pharmala Biotech Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmala Biotech Holdings's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmala Biotech Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Pharmala Biotech Holdings's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

Pharmala Biotech Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Pharmala Biotech Holdings's Pretax Income for the fiscal year that ended in Aug. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.644	+	-0.18	+	0	+	0	+	1.1102230246252E-16
	=	-0.82

Pharmala Biotech Holdings's Pretax Income for the quarter that ended in Nov. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.443	+	-0.036	+	0	+	0	+	0
	=	-0.48

Pre-Tax Income for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.70 Mil.

Pharmala Biotech Holdings (XCNQ:MDMA) Pre-Tax Income Explanation

Pharmala Biotech Holdings's Pretax Margin for the quarter that ended in Nov. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.479	/	0.057
	=	-840.35%

During the past 4 years, Pharmala Biotech Holdings's highest Pretax Margin was -79.61%. The lowest was -1264.10%. And the median was -146.62%.

Pharmala Biotech Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (XCNQ:MDMA) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

MDXXF:USA

Address

1 Adelaide Street East, Suite 801, Toranto, ON, CAN, M5C 2V9

Website

https://www.pharmala.ca

Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. Its drug API is manufactured and encapsulated under GMP conditions. The company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations and royalties from licensing of its IP.

Executives

Fraser Macdonald	Director
Perry Tsergas	Director
Shane H.d. Morris	Director, Senior Officer
Nicholas Kadysh	Director, Senior Officer

Pharmala Biotech Holdings Headlines

No Headlines